At the same time, butyrate supplementation promotes the expression of anti-tumor cytokines in cytotoxic CD8+ T cells by regulating the T cell receptor (TCR) signaling pathway, enhancing anti-tumor immunity (Zhu et al., 2023). This evidence concerns the gene CD8A and neoplasm.